Correlation between pre-existing MEK1(P124) mutations and clinical and in vitro response to BRAF inhibitors in metastatic melanoma

Matteo S. Carlino, Carina Fung, Hamideh Shahheydari, Jason R. Todd, Richard A. Scolyer, Richard Kefford, Georgina V. Long, Helen Rizos

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)9004-9004
Number of pages1
JournalJournal of Clinical Oncology
Issue number15 supplement
Publication statusPublished - 20 May 2014
Event50th Annual Meeting of the American-Society-of-Clinical-Oncology - Chicago, United States
Duration: 30 May 20143 Jun 2014

Cite this